Premium Nahrungsergänzungsmittel | artgerecht

Pannus Formation: Causes, Symptoms & Treatment

Pannus formation refers to the growth of inflammatory granulation tissue in joints that can destroy cartilage and bone over time.

Regular tips about health Regular tips about health

Things worth knowing about "Pannus formation"

Pannus formation refers to the growth of inflammatory granulation tissue in joints that can destroy cartilage and bone over time.

What is Pannus Formation?

Pannus formation refers to the development of pannus tissue – an aggressive, inflammatory granulation tissue – within joints. This tissue originates from the synovial membrane (the inner lining of joints) and spreads over the articular cartilage and adjacent bone. The term derives from the Latin word pannus (meaning “cloth”), describing the cloth-like manner in which this tissue spreads across the joint surface. Pannus tissue is a hallmark of rheumatoid arthritis (RA) and is considered a key mechanism behind the joint destruction associated with this disease.

Causes and Development

Pannus formation results from a chronic inflammatory response in the synovial membrane. The following mechanisms are involved:

Activation of synovial cells: In rheumatoid arthritis, synoviocytes are persistently activated by immune cells such as T-lymphocytes and macrophages.
Release of inflammatory mediators: Cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) drive the uncontrolled proliferation of the synovial membrane.
Neoangiogenesis: New blood vessels form within the pannus tissue, supplying it with nutrients and oxygen to sustain further growth.
Invasion of cartilage and bone: Pannus tissue releases destructive enzymes including matrix metalloproteinases (MMPs) and cathepsins that degrade cartilage and bone.

Beyond rheumatoid arthritis, pannus formation can also occur in other inflammatory joint diseases such as juvenile idiopathic arthritis and psoriatic arthritis.

Symptoms and Clinical Significance

Pannus tissue itself does not cause directly perceptible symptoms, but it drives the characteristic complaints of the underlying joint condition:

Joint pain and swelling, particularly in the morning
Morning stiffness lasting more than one hour
Reduced range of motion in affected joints
Cartilage degradation and long-term joint deformity
In advanced stages: joint destruction and loss of joint function

The aggressive nature of pannus tissue is a key reason why rheumatoid arthritis can lead to permanent joint and functional damage if not adequately treated.

Diagnosis

Pannus tissue is primarily identified through imaging techniques:

Magnetic resonance imaging (MRI): The most sensitive method for early detection of pannus tissue, cartilage damage, and bone erosions.
Ultrasound: Allows real-time assessment of synovial membrane thickening and pannus growth; Doppler mode visualizes increased blood flow within the tissue.
X-ray: Reveals advanced bone erosions and joint changes, but only in later stages of the disease.
Laboratory tests: Elevated inflammatory markers (CRP, ESR), rheumatoid factor (RF), and anti-CCP antibodies support the diagnosis of the underlying disease.

Treatment

Treatment aims to suppress the inflammatory response and halt further pannus growth. The following therapeutic options are available:

Pharmacological Therapy

Disease-modifying antirheumatic drugs (DMARDs): Methotrexate is the first-line agent and inhibits immune cell proliferation and inflammatory signaling.
Biologics: TNF-α inhibitors (e.g., adalimumab, etanercept), IL-6 inhibitors (e.g., tocilizumab), and other biological agents target specific steps in the inflammatory cascade and can effectively reduce pannus growth.
JAK inhibitors: Newer agents such as tofacitinib block intracellular signaling pathways that promote inflammation.
Corticosteroids: Used for short-term inflammation control, but less suitable for long-term therapy due to side effects.

Non-pharmacological Therapy

Physiotherapy: Maintains joint mobility and strengthens surrounding muscles.
Occupational therapy: Adapts daily activities to reduce strain on affected joints.

Surgical Therapy

Synovectomy: Surgical or arthroscopic removal of the inflamed synovial membrane and pannus tissue in treatment-resistant cases.
Joint replacement: In cases of severe joint destruction, a prosthetic joint (endoprosthesis) may be necessary.

References

Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. The Lancet, 2016;388(10055):2023–2038.
Firestein GS. Evolving concepts of rheumatoid arthritis. Nature, 2003;423(6937):356–361.
National Institute for Health and Care Excellence (NICE). Rheumatoid arthritis in adults: management. NICE guideline NG100. 2018. Available at: https://www.nice.org.uk

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.